The Daily Buyout

The archive

Every deal we've covered

1,770 deals tracked since Aug 26, 2026, worth $628B in announced deal value. Every link is free to read.

1,770 deals · $5.5B announced on this pagePage 3 of 89
UndisclosedTake-privateHealthcare & Life SciencesNov 10, 2026

Surgery Partners amends HealthSpan buyout after unsolicited rival bid

Surgery Partners and HealthSpan Partners, an affiliate of Bon Secours Mercy Health, have amended their previously announced merger agreement. The change follows Surgery Partners' receipt of an unsolicited competing proposal from an unnamed third party. Surgery Partners is a short-stay surgical facility owner and operator.

$25MStrategic acquisitionTechnologyNov 10, 2026

Enghouse to buy MIND CTI for $1.30 a share in cash

Enghouse Systems will acquire Nasdaq-listed MIND C.T.I., a provider of telecom billing and enterprise UC analytics software, for US$1.30 per share in cash, about $25.4 million in equity value and a 42% premium to the 30-day VWAP. MIND CTI can shop for better offers until December 10, with a $1 million break fee. Closing is expected in Q1 2027.

$2.8BPrivate equity buyoutMaterials & ChemicalsNov 10, 2026

KPS buys MM Packaging from Mayr-Melnhof at €2.4B enterprise value

KPS Capital Partners signed a deal to acquire MM Packaging from Mayr-Melnhof Karton for an enterprise value of €2.4 billion, with MM Group keeping a 30% stake. The Vienna-based maker of folding cartons, labels and leaflets runs more than 50 plants in 19 countries with about 8,500 employees. It will become a standalone company.

$1.6BPrivate equity buyoutConsumer & RetailNov 10, 2026

PSP Investments buys 50% of Enercare from Brookfield for $1.6B

Canada's PSP Investments agreed to acquire a 50% interest in Enercare from Brookfield and its institutional partners for $1.6 billion. Enercare provides water heaters, HVAC equipment, water purification and protection plans to more than 1.4 million Canadian homes and businesses. PSP has co-invested in Enercare alongside Brookfield since its 2018 privatization.

$550MStrategic acquisitionHealthcare & Life SciencesNov 10, 2026

Argenx buys peptide developer Unnatural Products for $550M upfront

Argenx will pay $550 million upfront to acquire California-based Unnatural Products, in a deal that could reach about $1 billion. The target's macrocyclic peptide platform will be used to develop oral, durable medicines for immune-mediated diseases. Argenx already held a minority stake after more than two years of collaboration.

UndisclosedStrategic acquisitionTechnologyNov 10, 2026

Siemens to buy chip debug specialist Lauterbach

Siemens signed an agreement to acquire Lauterbach, a provider of hardware-assisted debuggers and real-time trace tools for embedded software and complex system-on-chip designs. Siemens plans to combine Lauterbach's tools with its hardware-assisted verification portfolio. Financial terms were not disclosed.